アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/24 | 1,979 | 1,985 | 1,939.5 | 1,971.5 | -27 | -1.4% | 4,350,600 |
2022/03/23 | 1,971 | 2,002 | 1,968.5 | 1,998.5 | +53 | +2.7% | 4,059,300 |
2022/03/22 | 1,910 | 1,945.5 | 1,910 | 1,945.5 | +35.5 | +1.9% | 5,230,600 |
2022/03/18 | 1,919 | 1,919 | 1,881 | 1,910 | -1 | -0.1% | 6,937,100 |
2022/03/17 | 1,910 | 1,912 | 1,870.5 | 1,911 | +36.5 | +1.9% | 5,821,700 |
2022/03/16 | 1,872.5 | 1,887.5 | 1,863.5 | 1,874.5 | +23.5 | +1.3% | 6,570,200 |
2022/03/15 | 1,865 | 1,865 | 1,782 | 1,851 | -41.5 | -2.2% | 8,377,000 |
2022/03/14 | 1,885.5 | 1,930.5 | 1,875 | 1,892.5 | +47 | +2.5% | 5,621,800 |
2022/03/11 | 1,823 | 1,864.5 | 1,820.5 | 1,845.5 | +20 | +1.1% | 7,345,600 |
2022/03/10 | 1,797 | 1,828 | 1,786.5 | 1,825.5 | +26.5 | +1.5% | 7,706,900 |
2022/03/09 | 1,843 | 1,850 | 1,796 | 1,799 | -59 | -3.2% | 7,895,300 |
2022/03/08 | 1,869.5 | 1,894.5 | 1,843.5 | 1,858 | +13 | +0.7% | 8,661,800 |
2022/03/07 | 1,805.5 | 1,854 | 1,801 | 1,845 | +13.5 | +0.7% | 7,330,300 |
2022/03/04 | 1,880.5 | 1,881.5 | 1,829 | 1,831.5 | -49.5 | -2.6% | 7,764,500 |
2022/03/03 | 1,882.5 | 1,894.5 | 1,872 | 1,881 | +19 | +1% | 7,612,100 |
2022/03/02 | 1,908 | 1,919 | 1,846 | 1,862 | -46.5 | -2.4% | 8,289,500 |
2022/03/01 | 1,900 | 1,924.5 | 1,900 | 1,908.5 | -10 | -0.5% | 9,105,800 |
2022/02/28 | 1,911 | 1,938 | 1,906 | 1,918.5 | -4 | -0.2% | 7,128,000 |
2022/02/25 | 1,925 | 1,946.5 | 1,906 | 1,922.5 | +0.5 | ±0% | 6,808,600 |
2022/02/24 | 1,934 | 1,937 | 1,908 | 1,922 | -77.5 | -3.9% | 9,993,300 |
2022/02/22 | 1,990.5 | 2,010.5 | 1,969 | 1,999.5 | +9 | +0.5% | 4,897,900 |
2022/02/21 | 1,983 | 1,999 | 1,977 | 1,990.5 | -1 | -0.1% | 3,639,800 |
2022/02/18 | 1,985.5 | 2,005.5 | 1,985.5 | 1,991.5 | -26.5 | -1.3% | 5,256,500 |
2022/02/17 | 2,025 | 2,044.5 | 2,008.5 | 2,018 | +4 | +0.2% | 4,832,900 |
2022/02/16 | 1,999.5 | 2,024 | 1,994.5 | 2,014 | +42.5 | +2.2% | 4,495,900 |
2022/02/15 | 1,983.5 | 2,008 | 1,961 | 1,971.5 | -12 | -0.6% | 5,133,700 |
2022/02/14 | 1,981.5 | 1,994.5 | 1,952 | 1,983.5 | -45.5 | -2.2% | 6,587,300 |
2022/02/10 | 2,027.5 | 2,042 | 2,013.5 | 2,029 | +1.5 | +0.1% | 7,076,600 |
2022/02/09 | 2,031.5 | 2,042 | 2,006 | 2,027.5 | -18.5 | -0.9% | 6,101,400 |
2022/02/08 | 2,017 | 2,052 | 2,013 | 2,046 | +24.5 | +1.2% | 5,569,900 |
2022/02/07 | 1,983 | 2,028 | 1,982.5 | 2,021.5 | +22 | +1.1% | 5,282,600 |
2022/02/04 | 1,949 | 2,008 | 1,946.5 | 1,999.5 | +27.5 | +1.4% | 6,334,700 |
2022/02/03 | 1,946 | 1,976 | 1,907.5 | 1,972 | +26 | +1.3% | 7,315,900 |
2022/02/02 | 1,857.5 | 1,955 | 1,855 | 1,946 | +84.5 | +4.5% | 6,826,100 |
2022/02/01 | 1,825 | 1,877.5 | 1,823.5 | 1,861.5 | +11 | +0.6% | 4,581,200 |
2022/01/31 | 1,870.5 | 1,872 | 1,824.5 | 1,850.5 | -30 | -1.6% | 4,924,300 |
2022/01/28 | 1,846 | 1,892 | 1,846 | 1,880.5 | +26.5 | +1.4% | 4,921,000 |
2022/01/27 | 1,900 | 1,904.5 | 1,845.5 | 1,854 | -30 | -1.6% | 5,176,400 |
2022/01/26 | 1,928 | 1,931.5 | 1,877 | 1,884 | -55.5 | -2.9% | 3,866,300 |
2022/01/25 | 1,897 | 1,939.5 | 1,877 | 1,939.5 | +14 | +0.7% | 5,107,500 |
2022/01/24 | 1,935 | 1,938 | 1,906.5 | 1,925.5 | -8 | -0.4% | 3,202,300 |
2022/01/21 | 1,901.5 | 1,939.5 | 1,892.5 | 1,933.5 | +30.5 | +1.6% | 3,267,800 |
2022/01/20 | 1,895 | 1,925 | 1,889.5 | 1,903 | +9.5 | +0.5% | 3,071,000 |
2022/01/19 | 1,900 | 1,914.5 | 1,885 | 1,893.5 | -34.5 | -1.8% | 4,308,900 |
2022/01/18 | 1,935.5 | 1,947 | 1,915.5 | 1,928 | -2 | -0.1% | 2,758,800 |
2022/01/17 | 1,918.5 | 1,954 | 1,902 | 1,930 | +51.5 | +2.7% | 3,468,400 |
2022/01/14 | 1,900 | 1,900.5 | 1,862.5 | 1,878.5 | -17 | -0.9% | 4,899,400 |
2022/01/13 | 1,891.5 | 1,902 | 1,887.5 | 1,895.5 | ±0 | ±0% | 3,034,500 |
2022/01/12 | 1,880 | 1,903 | 1,880 | 1,895.5 | +16.5 | +0.9% | 3,240,100 |
2022/01/11 | 1,878 | 1,890 | 1,861.5 | 1,879 | +24.5 | +1.3% | 3,807,800 |
701~
750
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 147,700円 | +18.5% | -96.0% | 5.01% | 188.87倍 | 1.73倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 412,100円 | +7.7% | +206.9% | 4.76% | 55.36倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 798,500円 | +14.4% | +120.8% | 1.50% | 17.87倍 | 1.64倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 214,300円 | +5.7% | +3.9% | 2.68% | 10.66倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 440,600円 | +1.7% | -2.9% | 3.63% | 28.91倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム